Risk of Suicide After Cancer Diagnosis in England.


Journal

JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550

Informations de publication

Date de publication:
01 01 2019
Historique:
pubmed: 27 11 2018
medline: 15 2 2020
entrez: 27 11 2018
Statut: ppublish

Résumé

A diagnosis of cancer carries a substantial risk of psychological distress. There has not yet been a national population-based study in England of the risk of suicide after cancer diagnosis. To quantify suicide risk in patients with cancers in England and identify risk factors that may assist in needs-based psychological assessment. Population-based study using data from the National Cancer Registration and Analysis Service in England linked to death certification data of 4 722 099 individuals (22 million person-years at risk). Patients (aged 18-99 years) with cancer diagnosed from January 1, 1995, to December 31, 2015, with follow-up until August 31, 2017, were included. Diagnosis of malignant tumors, excluding nonmelanoma skin cancer. All deaths in patients that received a verdict of suicide or an open verdict at the inquest. Standardized mortality ratios (SMRs) and absolute excess risks (AERs) were calculated. Of the 4 722 099 patients with cancer, 50.3% were men and 49.7% were women. A total of 3 509 392 patients in the cohort (74.3%) were aged 60 years or older when the diagnosis was made. A total of 2491 patients (1719 men and 772 women) with cancer died by suicide, representing 0.08% of all deaths during the follow-up period. The overall SMR for suicide was 1.20 (95% CI, 1.16-1.25) and the AER per 10 000 person-years was 0.19 (95% CI, 0.15-0.23). The risk was highest among patients with mesothelioma, with a 4.51-fold risk corresponding to 4.20 extra deaths per 10 000 person-years. This risk was followed by pancreatic (3.89-fold), esophageal (2.65-fold), lung (2.57-fold), and stomach (2.20-fold) cancer. Suicide risk was highest in the first 6 months following cancer diagnosis (SMR, 2.74; 95% CI, 2.52-2.98). Despite low absolute numbers, the elevated risk of suicide in patients with certain cancers is a concern, representing potentially preventable deaths. The increased risk in the first 6 months after diagnosis may indicate an unmet need for psychological support. The findings of this study suggest a need for improved psychological support for all patients with cancer, and attention to modifiable risk factors, such as pain, particularly in specific cancer groups.

Identifiants

pubmed: 30476945
pii: 2714596
doi: 10.1001/jamapsychiatry.2018.3181
pmc: PMC6583458
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

51-60

Subventions

Organisme : Medical Research Council
ID : G0802441
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L501487/1
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

J Behav Med. 2003 Jun;26(3):265-81
pubmed: 12845938
Psychooncology. 2012 Apr;21(4):351-6
pubmed: 21264989
BMJ. 2016 Sep 12;354:i4515
pubmed: 27618829
BMJ. 2011 Oct 05;343:d6030
pubmed: 21980064
IARC Sci Publ. 1987;(82):1-406
pubmed: 3329634
Int J Cancer. 2009 Jun 15;124(12):2917-22
pubmed: 19330831
Stat Med. 2004 Jan 15;23(1):51-64
pubmed: 14695639
Arch Gen Psychiatry. 2012 Mar;69(3):256-64
pubmed: 22393218
Scand J Public Health. 2005;33(3):208-14
pubmed: 16040462
Suicide Life Threat Behav. 2008 Dec;38(6):650-60
pubmed: 19152296
J R Soc Med. 2014 May;107(5):194-204
pubmed: 24526464
Psychol Med. 2006 Feb;36(2):145-57
pubmed: 16420711
J Clin Oncol. 2004 Oct 15;22(20):4209-16
pubmed: 15483032
BMJ. 2018 Apr 25;361:k1415
pubmed: 29695476
BMJ. 2017 Oct 17;359:j4627
pubmed: 29042363
Ann Oncol. 2007 Feb;18(2):381-7
pubmed: 17053045
Br J Cancer. 2009 Jul 7;101(1):198-201
pubmed: 19471277
Br J Clin Pharmacol. 2010 Jan;69(1):4-14
pubmed: 20078607
Lancet Oncol. 2011 Feb;12(2):160-74
pubmed: 21251875
Lancet Psychiatry. 2014 Oct;1(5):343-50
pubmed: 26360998
Br J Cancer. 2012 Sep 25;107(7):1195-202
pubmed: 22892390
Lancet Psychiatry. 2018 Apr;5(4):321-326
pubmed: 29544711
N Engl J Med. 2012 Apr 5;366(14):1310-8
pubmed: 22475594
Lancet Psychiatry. 2016 Jul;3(7):646-59
pubmed: 27289303
Cancer Nurs. 2012 Jul-Aug;35(4):E14-26
pubmed: 21946906
Pain. 2016 May;157(5):1079-84
pubmed: 26761386
Psychooncology. 2010 Dec;19(12):1250-8
pubmed: 20213857

Auteurs

Katherine E Henson (KE)

National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.

Rachael Brock (R)

Bury St Edmunds GP Specialty Training Programme, West Suffolk Hospital, Bury St Edmunds, United Kingdom.

James Charnock (J)

National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.

Bethany Wickramasinghe (B)

National Cancer Registration and Analysis Service, Public Health England, Wellington House, London, United Kingdom.
Transforming Cancer Services Team for London, Skipton House, London, United Kingdom.

Olivia Will (O)

Department of Surgery, West Suffolk National Health Service Foundation, Bury St Edmunds, Suffolk, United Kingdom.

Alexandra Pitman (A)

UCL Division of Psychiatry, University College London, London, United Kingdom.
Camden and Islington National Health Service Foundation Trust, St Pancras Hospital, London, United Kingdom.
St George's University Hospitals National Health Service Foundation Trust, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH